Biomarkers for Immune Therapy in Gastrointestinal Cancers

Abstract: Immunotherapy with checkpoint blockade of pro-grammed death 1 (PD-1) and cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) has substantially increased the number of anticancer agents in […]

Checkpoint Inhibition in Lymphoma

Abstract: Checkpoint inhibition improves surveillance by the immune system and therefore outcomes in some lymphoma subtypes. In this review, we examine the available evidence regarding […]